OA08508A - Unsymmetrical derivatives of 1,4-dihydropyridine-3,5-dicarboxylic acid, methods of preparation and use in therapy. - Google Patents
Unsymmetrical derivatives of 1,4-dihydropyridine-3,5-dicarboxylic acid, methods of preparation and use in therapy.Info
- Publication number
- OA08508A OA08508A OA59099A OA59099A OA08508A OA 08508 A OA08508 A OA 08508A OA 59099 A OA59099 A OA 59099A OA 59099 A OA59099 A OA 59099A OA 08508 A OA08508 A OA 08508A
- Authority
- OA
- OAPI
- Prior art keywords
- group
- therapy
- dicarboxylic acid
- dihydropyridine
- preparation
- Prior art date
Links
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- COLPLFZHPXIFCQ-UHFFFAOYSA-N 1,4-dihydropyridine-3,5-dicarboxylic acid Chemical class OC(=O)C1=CNC=C(C(O)=O)C1 COLPLFZHPXIFCQ-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 150000002148 esters Chemical class 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- -1 nitro, hydroxyl Chemical group 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Laminated Bodies (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Photoreceptors In Electrophotography (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Coloring (AREA)
Abstract
The present invention relates to novel asymmetrical esters derived from 1,4-dihydrophyridine-3,5-dicarboxylic acid, of the formula: <IMAGE> (I) in which: R1 represents a C1-C4 alkyl group, R2 represents a C1-C4 alkyl group, a benzyl group, a benzoyl group or a phenyl group optionally substituted by one or more C1-C4 alkoxy, C1-C4 alkyl, cyano, nitro, hydroxyl or trifluoromethyl groups or by one or more halogen atoms, and R3 and R4, which are identical or different, each represent the hydrogen atom, a nitro group or a chlorine atom, their optical isomers and diastereoisomers and also the corresponding addition salts. These novel esters are useful in therapy, especially as antihypertensives.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8604685A FR2596760B1 (en) | 1986-04-02 | 1986-04-02 | DISSYMMETRIC DERIVATIVES OF 1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLIC ACID, METHODS OF PREPARATION AND THERAPEUTIC USE |
Publications (1)
Publication Number | Publication Date |
---|---|
OA08508A true OA08508A (en) | 1988-07-29 |
Family
ID=9333794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA59099A OA08508A (en) | 1986-04-02 | 1987-03-31 | Unsymmetrical derivatives of 1,4-dihydropyridine-3,5-dicarboxylic acid, methods of preparation and use in therapy. |
Country Status (25)
Country | Link |
---|---|
US (2) | US4806544A (en) |
EP (1) | EP0240398B1 (en) |
JP (1) | JPS6317883A (en) |
KR (1) | KR900005956B1 (en) |
CN (1) | CN1015460B (en) |
AT (1) | ATE63555T1 (en) |
AU (2) | AU590690B2 (en) |
CS (1) | CS268828B2 (en) |
DD (2) | DD278793A5 (en) |
DE (1) | DE3770037D1 (en) |
DK (1) | DK161787A (en) |
ES (1) | ES2028886T3 (en) |
FI (1) | FI86302C (en) |
FR (1) | FR2596760B1 (en) |
GR (1) | GR3002267T3 (en) |
HU (2) | HU199479B (en) |
IL (1) | IL81933A (en) |
NO (1) | NO167029C (en) |
NZ (1) | NZ219758A (en) |
OA (1) | OA08508A (en) |
PT (1) | PT84560B (en) |
SU (1) | SU1586515A3 (en) |
TN (1) | TNSN87043A1 (en) |
YU (2) | YU57287A (en) |
ZA (1) | ZA872258B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4092406D2 (en) * | 1989-12-22 | 1993-04-01 | Byk Gulden Lomberg Chem Fab | Neue dihydropyridine |
DE4125271A1 (en) * | 1991-07-31 | 1993-02-11 | Bayer Ag | NEW N-ALKYLATED 1,4-DIHYDROPYRIDINDICARBONIC ACID ESTERS |
WO1993006082A1 (en) * | 1991-09-13 | 1993-04-01 | Merck & Co., Inc. | Process for the preparation of 4-substituted-1,4-dihydropyridines |
AU2010227195B2 (en) * | 2009-03-27 | 2016-04-14 | Council Of Scientific And Industrial Research | Substituted 1, 4-dioxa-8-azaspiro [4,5] decanes useful as fungicides and a process for the preparation thereof |
WO2012123966A1 (en) | 2011-03-04 | 2012-09-20 | Arch Pharmalabs Limited | Process for the preparation of 4 -substituted -1, 4-dihydropyridines |
CN102796111B (en) * | 2012-09-10 | 2014-09-24 | 贵州大学 | Carboxylate (sulfonate) ester compounds of oxazepine spirocyclic amide group, preparation method and use |
CN104860873A (en) * | 2015-05-28 | 2015-08-26 | 石家庄学院 | Preparation method for (S)-1,4-dihydropyridine calcium ion antagonist |
CN108430989B (en) * | 2015-10-13 | 2021-10-08 | 轩竹生物科技有限公司 | Preparation method and intermediate of 1,4-dihydropyridine-3,5-dicarboxylate derivative |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1670824C3 (en) * | 1967-03-20 | 1978-08-03 | Bayer Ag, 5090 Leverkusen | 1,4-Dihydropyridine-33-dicarboxylic acid alkyl ester |
GB1245087A (en) * | 1967-10-26 | 1971-09-02 | Wyeth John & Brother Ltd | Heterocyclic compounds |
JPS4932542B1 (en) * | 1970-08-17 | 1974-08-31 | ||
GB1591089A (en) * | 1976-12-17 | 1981-06-10 | Fujisawa Pharmaceutical Co | 1,4-dihydropyridine derivatives and process for preparation thereof |
US4250312A (en) * | 1979-12-28 | 1981-02-10 | Argus Chemical Corp. | Process for preparing 4-piperidone spiroketal compounds |
US4250313A (en) * | 1980-02-01 | 1981-02-10 | Argus Chemical Corp. | Process for preparing 4-piperidone spiroketal compounds |
DE3208628A1 (en) * | 1982-03-10 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | NEW COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
JPS58159462A (en) * | 1982-03-17 | 1983-09-21 | Yoshitomi Pharmaceut Ind Ltd | 1,4-dihydropyridine-3,5-dicarboxylic acid ester derivative |
WO1983003249A1 (en) * | 1982-03-17 | 1983-09-29 | Yoshitomi Pharmaceutical | 1,4-dihydropyridine-3,5-dicarboxylate derivatives |
FR2577552B1 (en) * | 1985-02-20 | 1987-09-04 | Sori Soc Rech Ind | DISSYMMETRIC HETEROCYCLIC ESTERS OF 1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLIC ACIDS, METHOD OF PREPARATION AND THERAPEUTIC USE |
-
1986
- 1986-04-02 FR FR8604685A patent/FR2596760B1/en not_active Expired
-
1987
- 1987-03-18 IL IL81933A patent/IL81933A/en unknown
- 1987-03-18 ES ES198787400598T patent/ES2028886T3/en not_active Expired - Lifetime
- 1987-03-18 AT AT87400598T patent/ATE63555T1/en not_active IP Right Cessation
- 1987-03-18 EP EP87400598A patent/EP0240398B1/en not_active Expired - Lifetime
- 1987-03-18 DE DE8787400598T patent/DE3770037D1/en not_active Expired - Fee Related
- 1987-03-18 US US07/027,262 patent/US4806544A/en not_active Expired - Fee Related
- 1987-03-19 AU AU70410/87A patent/AU590690B2/en not_active Ceased
- 1987-03-24 NZ NZ219758A patent/NZ219758A/en unknown
- 1987-03-25 TN TNTNSN87043A patent/TNSN87043A1/en unknown
- 1987-03-25 FI FI871316A patent/FI86302C/en not_active IP Right Cessation
- 1987-03-26 PT PT84560A patent/PT84560B/en not_active IP Right Cessation
- 1987-03-27 ZA ZA872258A patent/ZA872258B/en unknown
- 1987-03-30 DK DK161787A patent/DK161787A/en not_active IP Right Cessation
- 1987-03-31 OA OA59099A patent/OA08508A/en unknown
- 1987-03-31 NO NO871339A patent/NO167029C/en unknown
- 1987-04-01 CN CN87102452A patent/CN1015460B/en not_active Expired
- 1987-04-01 YU YU00572/87A patent/YU57287A/en unknown
- 1987-04-01 CS CS872292A patent/CS268828B2/en unknown
- 1987-04-01 SU SU874202348A patent/SU1586515A3/en active
- 1987-04-01 KR KR1019870003078A patent/KR900005956B1/en not_active Expired
- 1987-04-01 HU HU871403A patent/HU199479B/en unknown
- 1987-04-01 DD DD87325139A patent/DD278793A5/en not_active IP Right Cessation
- 1987-04-01 HU HU893897A patent/HUT53080A/en unknown
- 1987-04-01 DD DD87301364A patent/DD263291A5/en not_active IP Right Cessation
- 1987-04-02 JP JP62083694A patent/JPS6317883A/en active Pending
-
1988
- 1988-03-09 YU YU480/88A patent/YU44714B/en unknown
- 1988-09-22 US US07/249,402 patent/US4900833A/en not_active Expired - Fee Related
-
1989
- 1989-09-11 AU AU41263/89A patent/AU610753B2/en not_active Ceased
-
1991
- 1991-07-05 GR GR91400959T patent/GR3002267T3/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3761307D1 (en) | MANUFACTURE OF FIBRATES. | |
DE122009000040I2 (en) | Naphthalene derivatives, processes for their preparation and pharmaceutical compositions containing them. | |
ES510402A0 (en) | A PROCEDURE FOR THE PREPARATION OF 1, -4DIHIDROPIRIDINAS. | |
DK287986A (en) | (METH) ACRYLIC ACID DERIVATIVES OF TRICYCLODECANES, THEIR PREPARATION AND USE AS DENTAL MATERIALS | |
TNSN87042A1 (en) | PROCESS FOR THE PREPARATION OF NEW STEROIDS HAVING A SPIRAN CYCLE IN POSITION 17 | |
DK0490566T3 (en) | Preparation and use of N-iodopropargyloxycarbonylamino acid esters and derivatives as antimicrobial agents | |
OA08508A (en) | Unsymmetrical derivatives of 1,4-dihydropyridine-3,5-dicarboxylic acid, methods of preparation and use in therapy. | |
AT389108B (en) | NEW PYRIDAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
ATE41772T1 (en) | POLYMETHOXYBENZYL PIPERAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES. | |
ATE32221T1 (en) | 3 N-SUBSTITUTED 3,4-DIHYDROPYRIMIDI DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS. | |
ATE69611T1 (en) | PIPERAZINYLALKYLPIPERAZINDONE DERIVATIVES, THEIR METHODS OF MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
DK484684A (en) | DERIVATIVES OF 4-ALKYL-2-HYDROXY-3-METHYL-2-PHENYLMORPHOLINE, PROCEDURES FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE | |
DE3269505D1 (en) | Substituted 1-benzoyl-2-phenylimino-imidazolidines, their acid addition salts, process for their preparation and pharmaceutical compositions containing them | |
DK469381A (en) | PIPERIDE INGREDIENTS AND PROCEDURES FOR THEIR PREPARATION | |
ATE17710T1 (en) | KETEN-0,0-ACETALS AND PROCESS FOR THEIR PRODUCTION. | |
OA08719A (en) | New acetamides derived from 2,3-dihydro-3-phenylbenzofuranone-2, processes for their preparation and pharmaceutical compositions containing them. |